Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Imma Mercadé"'
Autor:
Alba Andreu, Lilliam Flores, Marta Méndez, Ainize Ibarzabal, Gregori Casals, Imma Mercadé, Aina Borrás, Yasmina Barral, Inés Agustí, Dolors Manau, Josep Vidal, Gemma Casals
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionA reduction in anti-müllerian hormone (AMH) levels at short-term after bariatric surgery (BS) has been previously described. However, an assessment of ovarian reserve at longer-follow up, and a comprehensive evaluation of the potentially
Externí odkaz:
https://doaj.org/article/71e712e680e940c188c3a3b2137509fe
Autor:
Elena Casals, Stefania Triunfo, Francesc Figueras, Subhasis Banerjee, Laia Rodriguez-Revenga Bodi, Francesca Crovetto, Eduard Gratacós, Imma Mercadé, Walter E Mills, Anne E. Chambers, Luis Lasalvia, Michael Pugia, Fatima Crispi, Aurea Mira
Publikováno v:
Fetal Diagnosis and Therapy. 38:94-102
Objective: To explore the value of circulating luteinizing human chorionic gonadotropin receptor (LHCGR) forms for the prediction of preeclampsia (PE) in the first trimester of pregnancy. Methods: Case-control study, based on a cohort of 5,759 pregna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::174bdbfd6cb7d1c6781c9f219b3157b6
https://doi.org/10.1159/000371516
https://doi.org/10.1159/000371516
Autor:
Antoni Borrell, Imma Mercadé, J. A. Vanrell, A. Seres, Cararach, Albert Fortuny, Elena Casals, Anna Goncé, C González
Publikováno v:
Progresos de Obstetricia y Ginecología. 48:223-230
Resumen Objetivo Evaluar la efectividad del Test Combinado (bioquimica y ecografia en el primer trimestre) para la deteccion prenatal del syndrome de Down en la poblacion general. Material y metodos Se determinaron los marcadores bioquimicos de prime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69389055b3e642fa452c52e4b78180ad
https://doi.org/10.1016/s0304-5013(05)72387-6
https://doi.org/10.1016/s0304-5013(05)72387-6
Autor:
M. Angels Martínez, Anna Goncé, Elena Casals, Albert Fortuny, Antoni Borrell, Imma Mercadé, Vicenç Cararach, J. A. Vanrell
Publikováno v:
Prenatal Diagnosis. 25:1156-1161
Objective To evaluate the effectiveness of the addition of first-trimester biochemistry to fetal nuchal translucency (NT) measurement in the Combined Test when screening for trisomy 21 in twin pregnancies. Methods Maternal serum free β-hCG and PAPP-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc84bc87bb5b20ca942d3d721db73cc9
https://doi.org/10.1002/pd.1304
https://doi.org/10.1002/pd.1304
Autor:
Albert Fortuny, M. T. Farré, Antoni Borrell, V. Cararach, Elena Casals, Imma Mercadé, A. Seres
Publikováno v:
Progresos de Obstetricia y Ginecología. 47:257-263
Resumen Objetivo Estudio de la efectividad del cribado bioquimico y ecografico en el segundo trimestre de la gestacion para la deteccion prenatal de trisomia 21 en poblacion de bajo riesgo de aneuploidia. Metodo Estudio prospectivo de intervencion de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78a46dbd37aedb6ba7378ea2c417178b
https://doi.org/10.1016/s0304-5013(04)76001-x
https://doi.org/10.1016/s0304-5013(04)76001-x
Autor:
Silvia M. Lobmaier, Fatima Crispi, Imma Mercadé, Eduard Gratacós, Francesca Crovetto, Anna Peguero, Francesc Figueras, Javier U. Ortiz, M. Parra-Saavedra
Publikováno v:
Fetal diagnosis and therapy. 36(1)
Aim: To establish normal ranges of maternal placental growth factor (PlGF), soluble fms-like tyrosine kinase-1 (sFlt-1) and sFlt-1/PlGF ratio at 32-41 weeks' gestation and to evaluate the influence of maternal characteristics, and of fetoplacental Do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a12dfd4a9c26fde4adf6d090c11fb30
https://pubmed.ncbi.nlm.nih.gov/24903330
https://pubmed.ncbi.nlm.nih.gov/24903330
Autor:
A. Sanjuán, Carlos Ascaso, Geòrgia Escaramís, Imma Mercadé, Camil Castelo-Branco, Elena Casals, J J Vicente, Jaume Ordi, J. A. Vanrell, Marta Colodrón
Publikováno v:
Maturitas. 45(1)
Background: Different hormonal replacement regimens are used for treating climacteric complaints; however, not all of them have the same clinical profile. Cardiovascular disease (CVD) is a major health problem and tibolone, raloxifene, estradiol (alo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87e8871c7f6cc906e891cdc9224f5120
https://pubmed.ncbi.nlm.nih.gov/12753945
https://pubmed.ncbi.nlm.nih.gov/12753945